Hepatitis B Virus Immunization and Neonatal Acquisition of Persistent Infection in England and Wales

Background: It is believed that between 2% and 5% of infants born to hepatitis B virus (HBV)-infected mothers at a high risk of perinatal transmission will become persistently infected despite immunization starting at birth. We investigated factors associated with breakthrough infections.

Methods: Sixty-nine samples from HBV-infected infants born between 2003 and 2015 were tested for HBV serological and molecular markers. Sequencing and epitope phenotyping were used to investigate alterations in hepatitis B surface antigen (HBsAg) sequence and antigenicity in infants and in mothers known to have transmitted and not to have transmitted virus to their infants.

Results: Vaccine/hepatitis B immune globulin uptake was complete in the majority of HBV-infected infants. A minority (8 [12%]) had detectable plasma antibody to HBsAg at 12 months. Twenty-five of 68 (37%) infants harbored a virus with amino acid changes in the HBsAg "a" determinant, of which 13 displayed altered HBsAg antigenicity. Viral load was 30-fold higher in maternal samples from those who transmitted.

Conclusions: Our data provide evidence to suggest that immune selection drives change at mother-infant transmission, resulting in the alteration of HBsAg antigenicity. These changes may play a role in immunization failure, but other factors including viral load may be more important. Continued monitoring of vaccine efficacy is essential.

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:218

Enthalten in:

The Journal of infectious diseases - 218(2018), 5 vom: 24. Juli, Seite 726-733

Sprache:

Englisch

Beteiligte Personen:

May, Shoshanna [VerfasserIn]
Mandal, Sema [VerfasserIn]
Keel, Philip [VerfasserIn]
Haywood, Becky [VerfasserIn]
Ngui, Siew Lin [VerfasserIn]
Ramsay, Mary [VerfasserIn]
Tedder, Richard S [VerfasserIn]
Ijaz, Samreen [VerfasserIn]

Links:

Volltext

Themen:

Epitopes
Hepatitis B Surface Antigens
Hepatitis B Vaccines
Journal Article
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 10.09.2019

Date Revised 10.09.2019

published: Print

Citation Status MEDLINE

doi:

10.1093/infdis/jiy209

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM283362359